Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Increases By 247.1%

Azitra, Inc. (NYSEAMERICAN:AZTR) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 435,300 shares, an increase of 247.1% from the May 31st total of 125,400 shares. Based on an average daily volume of 1,880,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.7% of the shares of the stock are short sold.

Azitra Stock Down 30.2 %

Shares of Azitra stock traded down $0.04 during mid-day trading on Friday, hitting $0.09. 3,365,822 shares of the stock were exchanged, compared to its average volume of 3,520,313. The company has a quick ratio of 2.80, a current ratio of 2.80 and a debt-to-equity ratio of 0.01. Azitra has a twelve month low of $0.09 and a twelve month high of $4.33.

Azitra shares are going to reverse split on Monday, July 1st. The 1-30 reverse split was announced on Monday, July 1st. The number of shares owned by shareholders will be adjusted after the market closes on Monday, July 1st.

Azitra (NYSEAMERICAN:AZTR) last posted its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. Azitra had a negative net margin of 1,644.90% and a negative return on equity of 237.52%.

About Azitra

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.